Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers45

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers18

Views

Views
December 20241
January 20252
February 20256
March 20253
April 20253
May 20252
June 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Singapore3
Brazil1
Spain1
 

Top cities views

Views
Ashburn1
Cambridge1
Council Bluffs1
Rio de Janeiro1